Paper - WANFANG MED ONLINE

You Position: Home > Paper

胰腺癌分子分型的研究进展

( views:96, downloads:136 )

Author:: No author available

Journal Title:: Chinese Journal of Pancreatology

Issue:: 4

DOI:: 10.3760/cma.j.issn.1674-1935.2019.04.016

Key Word:: 分子分型;胰腺导管腺癌;亚型

Abstract：胰腺导管腺癌(PDAC)是世界上恶性程度最高的肿瘤之一,近年来发病率逐步升高,但其生存率并未有明显提高.PDAC表现为显著的异质性,而这为其分子分型提供了依据.随着二代测序技术的发展,PDAC的DNA、RNA、蛋白质等的突变模式也越来越清楚.本文旨在总结近年来PDAC的分子分型的研究进展.

Reference

[1]Collisson EA,Sadanandam A,Olson P,etc.Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy.[J].2011,17(4).
[2]Shindo, Koji,Yu, Jun,Suenaga, Masaya,etc.Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma[J].2017,35(30).
[3]Ludmil B. Alexandrov,Serena Nik-Zainal,David C. VVedge,etc.Signatures of mutational processes in human cancer[J].2013,500(Aug.22 TN.7463).
[4]Francesco,Puleo,Rémy,Nicolle,Yuna,Blum,etc.Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features.[J].2018.
[5]Tomokuni,A.,Doki,Y.,Iwagami,Y.,etc.MiR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1[J].2013,109(2).
[6]Goncalves A,Finetti P,Viret F,etc.Genome profiling of pancreatic adenocarcinoma.[J].2011,50(6).
[7]Aguirre, Andrew J.,Hruban, Ralph H.,Raphael, Benjamin J..Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma[J].2017,32(2).
[8]Isella, Claudio,Terrasi, Andrea,Bellomo, Sara Erika,etc.Stromal contribution to the colorectal cancer transcriptome[J].2015,47(4).
[9]Liu CG,Petrocca F,Bhatt D,etc.MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis.[J].2007,297(17).
[10]Xia,H.,Hui,K.M..MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics[J].2012,19(11).
[11]Qingxuan, Song,Sofia D, Merajver,Jun Z, Li.Cancer classification in the genomic era: five contemporary problems.[J].2015,9.
[12]Tomohiko, Harada,Kiwamu, Okita,Kei, Shiraishi,etc.Interglandular cytogenetic heterogeneity detected by comparative genomic hybridization in pancreatic cancer.[J].2002,62(3).
[13]Liu J,Bloomston M,Croce C,etc.MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival.[J].2008,12(12).
[14]Moffitt, Richard A.,Marayati, Raoud,Flate, Elizabeth L.,etc.Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma[J].2015,47(10).
[15]Rahib,L.,Smith,B.D.,Aizenberg,R.,etc.Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the united states[J].2014,74(11).
[16]Esquela Kerscher A,Slack FJ.Oncomirs - microRNAs with a role in cancer.[J].2006,6(4).
[17]Yi, Sung Gon,Han, Sangjo,Kang, Mee Joo,etc.Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value[J].2016,31(6).
[18]Cohen SJ,Alpaugh RK,Palazzo I,etc.Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma.[J].2008,37(2).
[19]Nones,K.,Waddell,N.,Song,S.,etc.Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling[J].2014,135(5).
[20]Li D,Xie K,Wolff R,etc.Pancreatic cancer.[J].2004,363(9414).
[21]Tuschl,T.,Farazi,T.A.,Morozov,P.,etc.MicroRNAs in human cancer.[J].2013,774.
[22]Siomi MC,Siomi H.Posttranscriptional regulation of microRNA biogenesis in animals.[J].2010,38(3).
[23]Waddell, Nicola,Pajic, Marina,Patch, Ann-Marie,etc.Whole genomes redefine the mutational landscape of pancreatic cancer[J].2015,518(Feb.26 TN.7540).
[24]Wartenberg, Martin,Cibin, Silvia,Zlobec, Inti,etc.Integrated Genomic and Immunophenotypic Classification of Pancreatic Cancer Reveals Three Distinct Subtypes with Prognostic/Predictive Significance[J].2018,24(18).
[25]Janky, Rekin's,Binda, Maria Mercedes,Allemeersch, Joke,etc.Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma.[J].2016.
[26]Peter, Bailey,David K, Chang,Katia, Nones,etc.Genomic analyses identify molecular subtypes of pancreatic cancer.[J].2016.
[27]Shuo, Gu,Mark A, Kay.How do miRNAs mediate translational repression?[J].2010,1(1).
[28]Kayashima T,Moriyama T,Ohtsuka T,etc.MicroRNA expression as a predictive marker for gemcitabine response after surgical resection of pancreatic cancer.[J].2011,18(8).
[29]Greither T,Grochola LF,Udelnow.Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival.[J].2010,126(1).
[30]Birnbaum DJ,Birnbaum D,Bertucci F.Endometriosis-associated ovarian carcinomas.[J].2011,364(5).
[31]Rubio Viqueira B,Jimeno A,Cusatis G,etc.An in vivo platform for translational drug development in pancreatic cancer.[J].2006,12(15).
[32]Seema, Sethi,Dejuan, Kong,Sue, Land,etc.Comprehensive molecular oncogenomic profiling and miRNA analysis of prostate cancer.[J].2013,5(2).